BSM options turn defensive as earnings loom in five days

Black Stone Minerals enters its Q3 earnings report with options traders showing the most defensive posture of the past year, a notable shift for a partnership that has spent most of 2026 outperforming its E&P peers by a wide margin.

The options signal is the sharpest data point this week. The put/call ratio has climbed to 0.75, nearly three standard deviations above its 20-day average of 0.54, making it the highest defensive reading BSM has logged in the past 12 months. That jump landed almost entirely in the final two sessions of the week. On October 16 the ratio was a benign 0.48. By October 20 it had reached 0.75, which puts it close to the 52-week ceiling of 0.89. The borrow market tells a completely different story. Availability is ample at roughly 976%, meaning around nine shares remain available to lend for every one already borrowed. Cost to borrow is just 0.60%, and it has drifted lower over the past month. Short interest is a modest 1.3% of the free float, having edged down over the week. There is no meaningful short pressure here. The options move looks like pre-earnings hedging, not a structural bet against the unit price.

The Street is holding a cautious but not bearish line. The consensus is a hold, with the most recent coverage initiated by RBC Capital in late May at a Sector Perform with a $16 target. Piper Sandler, which has tracked BSM closely, lifted its target to $14 in March after cutting it three times across 2024 and 2025. With BSM trading at $14.75, those targets bracket the current price tightly. The EPS surprise factor score of 82 is one of the stronger numbers in the snapshot: BSM has a track record of beating estimates, which gives the approaching print some context. The short score of 43.6 is mid-range and has been drifting lower from above 45 earlier in October, reflecting the easing borrow conditions rather than any fundamental shift.

The ownership picture carries one item worth noting. Director James Whitehead filed two open-market sales in early August, disposing of just over 2.1 million units at $13.21 for a combined value near $28 million. That represents a large transaction relative to BSM's daily volume. On the other side, five directors received unit grants on October 2 at $14.32, all routine compensation awards. The net 90-day insider figure is heavily negative at minus 2.1 million units in aggregate, driven almost entirely by the Whitehead sales. Morgan Stanley disclosed a fresh 13G stake of 5.2% as of August 20. That is a passive filing, not an activist position, and the standard caveat applies: positions are as last disclosed around the 5% threshold, and a holder can fall below without filing again.

BSM's peer group spent much of September in retreat. MUR gained over 10% for the week, and EOG, VNOM and COP each added 3% or more. BSM itself fell 1.2% over the same period, a reversal from the pattern seen through most of 2026, when BSM's royalty model gave it insulation from the capex-driven swings that hit working-interest operators. This week the direction flipped, with operating E&P names recovering while BSM drifted lower. The three prior earnings reactions are worth keeping in mind: BSM fell 3.3% on the day of its August 2026 report and was down 5.8% five days later. The two earlier reports also produced negative one-day moves.

The Q3 print drops on October 26. With options hedging at its highest level of the past year and the stock's own earnings history weighted to the downside, the question going into next week is whether BSM's distribution level and royalty volumes give the market any reason to revisit the hold consensus that has kept price targets clustered tightly around $14 to $16.